Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6519
    +0.0019 (+0.30%)
     
  • OIL

    82.99
    +0.18 (+0.22%)
     
  • GOLD

    2,334.10
    -4.30 (-0.18%)
     
  • Bitcoin AUD

    98,475.06
    -3,995.16 (-3.90%)
     
  • CMC Crypto 200

    1,390.79
    +8.22 (+0.59%)
     
  • AUD/EUR

    0.6081
    +0.0011 (+0.18%)
     
  • AUD/NZD

    1.0951
    +0.0009 (+0.08%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,078.94
    +38.56 (+0.48%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,987.96
    -100.74 (-0.56%)
     
  • Hang Seng

    17,274.10
    +72.83 (+0.42%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Could Vir Biotechnology Be a Millionaire Maker Stock?

Could Vir Biotechnology Be a Millionaire Maker Stock?

Vir Biotechnology (NASDAQ: VIR) may be weeks away from commercializing its very first product. The clinical-stage biotech company and partner GlaxoSmithKline late last month requested Emergency Use Authorization (EUA) for their investigational COVID-19 treatment. In more good news, GlaxoSmithKline recently expanded its collaboration with Vir to include the development of potential treatments for respiratory viruses including influenza.